A 26-year-old woman presented with several months' history of abdominal discomfort, postprandial bloating and nausea. The patient was otherwise well and had no significant medical or family history.
A computed tomography scan revealed a heterogeneous cystic and solid mass 14 cm in size in the right upper quadrant. There was no vascular involvement or lymphadenopathy, or biliary or pancreatic duct dilation (Figure 1A). Subsequent endoscopic ultrasound revealed a homogenous solid mass occupying most of the pancreas parenchyma (Figure IB). Fine-needle aspiration revealed abundant tumour cells, characterized by granular cytoplasm and round to oval nuclei with finely textured chromatin and an indistinct nucleolus (Figure 1C); in areas, the tumour cells surrounded delicate hyalinized fibrovascular cores (Figures 1C and ID). The tumour cells showed strong nuclear immunoreactivity for beta-catenin (Figure IE).
DISCUSSION
Solid pseudopapillary neoplasms (SPNs) are the rarest of the four subtypes of pancreatic cystic neoplasms, representing 1% to 3% of all pancreatic tumours and 10% to 15% of all pancreatic cystic neoplasms. This neoplasm was first reported in 1959, was subsequently classified by the WHO as a solid pseudopapillary tumour in 1996 and is now classified as SPN (1).
SPNs can be located in the tail, head or body of the pancreas. Affected patients are predominantly women of reproductive age who present with nonspecific symptoms: most commonly abdominal pain, nontender epigastric mass, nausea and vomiting. However, a significant proportion (15%) of patients are completely asymptomatic, thus making the clinical diagnosis challenging. While SPNs are typically benign lesions, they do have low-grade malignant potential. The recommended treatment is surgical resection, with a five-year survival rate >95% (2).
The endoscopic ultrasound appearance of SPNs is nondiagnostic, ranging from well-demarcated, solid-appearing masses, to mixed solid and cystic, and purely cystic lesions. Characteristic cytomorphological features include marked cellularity with pseudopapillary fragments composed of fibrovascular cores lined with discohesive neoplastic cells. Immunohistochemically, the majority are reactive for vimentin, alpha-1 antitrypsin and alpha-1-antichymotrypsin. An alteration in the adenomatous polyposis coli/beta-catenin pathyway has been demonstrated, resulting in nuclear accumulation of beta-catenin in SPNs (3).
REFERENCES
1. Bosman FT, Cameiro F, Hruban RH, Thiese ND. WHO Classification of Tumors of the Digestive System. Lyon: IARC, 2010.
2. Papavramidis P, Papavramidis S. Solid pseudopapillary tumors of the pancreas: Review of 718 patients reported in English literature. J Am Coll Surg 2005; 200:965-71.
3. Tanaka Y. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001;61:8401-4-
E Rayner-Hartley MD1, DF Schaeffer MD2, F Donnellan MD1
1 Division of Gastroenterology ; department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia
Correspondence: Dr F Donnellan, Division of Gastroenterology, Vancouver General Hospital, 2775 Laurel Street, Vancouver, British Columbia V5Z 1M9. Telephone 778-870-3464, e-mail [email protected]
Received for publication February 5, 2013. Accepted February 19, 2013
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Pulsus Group Inc. Apr 2013